Turnstone Biologics Corp [TSBX] stock prices are up 19.85% to $0.57 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TSBX shares have gain 20.03% over the last week, with a monthly amount glided 23.64%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Turnstone Biologics Corp [NASDAQ: TSBX] stock has seen the most recent analyst activity on October 14, 2024, when BofA Securities downgraded its rating to a Neutral. On August 15, 2023, Piper Sandler initiated with a Overweight rating and assigned a price target of $20 on the stock. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $18 on August 15, 2023.
The stock price of Turnstone Biologics Corp [TSBX] has been fluctuating between $0.44 and $5.75 over the past year. Currently, Wall Street analysts expect the stock to reach $0.5 within the next 12 months. Turnstone Biologics Corp [NASDAQ: TSBX] shares were valued at $0.57 at the most recent close of the market. An investor can expect a potential drop of -12.28% based on the average TSBX price forecast.
Analyzing the TSBX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.97, Equity is -0.85 and Total Capital is -1.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4498 points at the first support level, and at 0.3295 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6935, and for the 2nd resistance point, it is at 0.8169.
Ratios To Look Out For
It’s worth pointing out that Turnstone Biologics Corp [NASDAQ:TSBX]’s Current Ratio is 4.38. As well, the Quick Ratio is 4.38, while the Cash Ratio is 1.12.
